Peer Review History
| Original SubmissionSeptember 18, 2023 |
|---|
|
PONE-D-23-27473Impact of terminal cleaning in rooms previously occupied by patients with healthcare-associated infectionsPLOS ONE Dear Dr. Verhougstraete, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Feb 25 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Eili Y. Klein, PhD Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We suggest you thoroughly copyedit your manuscript for language usage, spelling, and grammar. If you do not know anyone who can help you do this, you may wish to consider employing a professional scientific editing service. Whilst you may use any professional scientific editing service of your choice, PLOS has partnered with both American Journal Experts (AJE) and Editage to provide discounted services to PLOS authors. Both organizations have experience helping authors meet PLOS guidelines and can provide language editing, translation, manuscript formatting, and figure formatting to ensure your manuscript meets our submission guidelines. To take advantage of our partnership with AJE, visit the AJE website (http://learn.aje.com/plos/) for a 15% discount off AJE services. To take advantage of our partnership with Editage, visit the Editage website (www.editage.com) and enter referral code PLOSEDIT for a 15% discount off Editage services. If the PLOS editorial team finds any language issues in text that either AJE or Editage has edited, the service provider will re-edit the text for free. Upon resubmission, please provide the following: The name of the colleague or the details of the professional service that edited your manuscript A copy of your manuscript showing your changes by either highlighting them or using track changes (uploaded as a *supporting information* file) A clean copy of the edited manuscript (uploaded as the new *manuscript* file) 3. Thank you for stating the following in the Acknowledgments Section of your manuscript: “The authors gratefully acknowledge the generous funding for this research from the US Centers for Disease Control and Prevention (CDC) under Contract number: 75D30118C02916. Specifically, we acknowledge Laura Rose and Sujan Reddy who provided support towards the project design, protocol development, and technical reviews of reports and manuscript. The authors acknowledge and appreciate the environmental sampling and processing efforts from Dr. Lisa Casanova at Georgia State University.” We note that you have provided funding information that is currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: “MV, MW US Centers for Disease Control and Prevention (CDC) under Contract number: 75D30118C02916 Yes: CDC scientists helped define appropriate confirmation tests for each pathogen” Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 4. Thank you for stating the following in your Competing Interests section: “No” Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state "The authors have declared that no competing interests exist.", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now This information should be included in your cover letter; we will change the online submission form on your behalf. 5. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process. 6. Please remove your figures from within your manuscript file, leaving only the individual TIFF/EPS image files, uploaded separately. These will be automatically included in the reviewers’ PDF. 7. Please keep your tables as part of your main manuscript and remove the individual files. Please note that supplementary tables (should remain/ be uploaded) as separate "supporting information" files Additional Editor Comments: Sorry for the delay in review. The original reviewer went out on parental leave and there was difficulty securing another reviewer. I agree with the reviewers that the paper is useful and adds to the literature on room cleaning, but that it needs some work. Some of the issues are methodological (e.g., why no negative control) some were questions on the statistical choices, and some were just comments on the readability. A major issue was a description of the surfaces. It appears this may have been in a citation, but that citation shows up as an error. Perhaps add some details about the surfaces here as well as correcting the citation. The other issue noted was the concern about increases at certain hospitals either in whole or part. There was confusion about what increased and how significant was that increases. There was particular concern around the tables which are not always clear. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Summary This study highlights the impact of terminal room cleaning on removing pathogens from high-touch surfaces. This is an absolutely important subject, particularly with potential implications for the role of environment in transmission of HAIs. The study includes the collection and analysis of environmental samples from 36 patient rooms at 3 major hospitals located in 3 different US states. The findings suggest that while complete eradication of pathogens to undetectable levels, which is the goal of most terminal cleaning protocols, was not consistently achieved, concentration levels of Acinetobacter baumannii, MRSA, VRE, and C diff. were moderately to significantly reduced after the cleaning procedure across different surface types. One interesting finding was the increase in VRE concentration on nurse call buttons after cleaning in one of the hospitals, which the authors argued to be potentially due to cross contamination. Another interesting finding, which agrees with other studies, was that using only ATP measurement was shown to be insufficient for assessing hospital surface cleanliness. The authors have provided suggestions about amending and standardizing current terminal cleaning protocols to protect patients from exposure to residual pathogens on surfaces left by previous patients, with a particular focus on MRSA and VRE as the most frequently found pathogens on hospital surfaces after terminal cleaning. In light of uncertainties regarding the effectiveness of terminal cleaning, the study suggests transitioning to a risk-based framework that can link terminal cleaning protocols to expected HAI outcomes. I found the study interesting and suitable for publication in PLOS ONE, though I have a few questions that I would like to be addressed before publication. Major comments/questions 1. The authors have provided a brief discussion of the potential impacts of the differences in cleaning protocols and compliance across the three sites on their findings, in addition to other limitation of their study (which is shared with other similar studies). I think it would help to make a more comprehensive discussion if other factors that may contribute to variabilities and rare but significant discrepancies (such as VRE increase in one of the hospitals) were also incorporated, factors such as differences in cleaning staff diligence, patient colonization rates, admission prevalence rate, average length of stay, frequency of HCW visits, and other factors that affect pathogen shedding and transfer and may differ across rooms, wards, and hospitals. 2. Discussion, Paragraph 2: “on at least one occasion, detections and/or concentrations increased from pre-cleaning to post-cleaning sampling. This occurred for C. difficile on chair handrail, MRSA on bed handrail…” While the “one” occasion was covered in the results section for VRE on nurse call buttons, other instances of such observations, where pathogen concentration was increased after terminal cleaning, was not explained neither could be interpreted from the results (Tables 2 and 3), for example C. difficile on chair handrail. I am not sure if these other instances were isolated cases in one or just a few rooms, or if the findings were not reliable due to below-detectable concentrations. What could be the reason? Please elaborate. 3. The one occasion where VRE concentration was increased after terminal cleaning is interesting. While the authors have provided their interpretation of the potential causes, it would make it easier for readers to objectively interpret such a rare but impactful case if more information was provided, for example, was this observed for all nurse call buttons (all rooms), if not how many of the rooms, and whether there could be anything different about those specific rooms or their occupying patients. This deserves a little deeper investigation. 4. Statistical analysis: what method was used for multiple hypothesis tests (detections) to correct for family-wise type I errors? If such a consideration was not necessary, please justify by explaining in the paper the scale of detection tests (i.e., whether detection tests were done on a surface-, room-, or hospital-level) in relation to the comparison scale which is surface type at each hospital. Minor comments 1. Abstract: Please spell out what ATP stands for, the first time it is used. 2. Abstract: Incomplete sentence: “Surfaces from 36 occupied … and Clostridioides difficile (C. difficile)).” 3. Abstract: Missing comma before “desk surface” in the following statement: “Six nonporous, high touch surfaces (i.e., chair handrail, bed handrail, nurse call button desk surface, bathroom counter near the sink, and a grab bar near the toilet) ...” 4. Introduction, Paragraph 1: “ATP as a biochemical indicator of biological material.” Incomplete sentence. Please complete or merge with the previous or next sentence. 5. Methods, Sample Site Selection, Paragraph 2: Missing comma before “desk surface” in the following statement: “The six surfaces (i.e., chair handrail, bed handrail, nurse call button desk surface, bathroom counter near the sink, and a grab bar near the toilet) ...” 6. Methods, Sample Site Selection, Paragraph 2: Please address the cross-referencing error. 7. Methods, Sample Site Selection, Paragraph 2: “If a pre-selected item was not present …” An example or two for the replacements could help clarify, also how often this was the case? 8. Methods, Sample Site Selection, Table 1: To improve readability, please align cells, preferably to the top left corner of the cells, or use borders. 9. Methods, Detections, below Figure 1: “At hospital 2, VRE was the only organism detected and confirmed (n nurse call button) pre-cleaning…” Please correct the typo inside the parentheses. 10. Discussion, Paragraph 4: “Other studies, however, have shown poor relationship relationships [38–41] …” Please remove the extra “relationship.” Reviewer #2: Thank you for this informative paper in this important area of infection prevention and control in the hospital setting. I have some comments that revolve primarily around making the paper clearer, and easier for the reader to understand and contextualize. It includes using a denominator to give context to the numbers you are referrring to. -The abstract needs to include the number of rooms being evaluated for each in order to make sense of these results. -The statement "ATP detections did not correlate with any pathogen concentration and thus are not recommended for assessing cleanliness or safety." is too conclusive based on the data shown. ATP measures organic matter, and would be better correlated with overall aerobic colony counts, it is not specific to multidrug resistant organisms. -In methods, there is an error: "Descriptions of the surfaces are presented in Error!Reference source not found.." -Include use of negative control in the micro methods section if used, or if not used explain why. - Presumptive and confirmed concentrations needs to be explained in the methods. From my reading/understanding only AB isolates from wet surfaces were confirmed as these may be non-baumanii. But then it seems to apply to all and is very unclear. Table 2 is also very unclear. - Detections needs a denominator to put the “51” and “12” on the first line in context. The rest of the section is unclear, and does not seem to align with the methods. -Discussion: needs to be clearer - Other studies, however, have shown poor relationship relationships [38–41] or significant relationships [42–47] between ATP and pathogen presence. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Fardad Haghpanah Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Impact of terminal cleaning in rooms previously occupied by patients with healthcare-associated infections PONE-D-23-27473R1 Dear Dr. Verhougstraete, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Eili Y. Klein, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Thank you for your diligence in responding to all the comments and your patience in the process Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) Reviewer #2: Thank you for addressing the reviewer comments. I do not have any further comments or edits to suggest. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Fardad Haghpanah Reviewer #2: No ********** |
| Formally Accepted |
|
PONE-D-23-27473R1 PLOS ONE Dear Dr. Verhougstraete, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Eili Y. Klein Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .